Biological Characterization of TAK-901, an Investigational, Novel, Multitargeted Aurora B Kinase InhibitorPamela Farrell, Ron de Jong, Takashi Hoshino et al.|Molecular Cancer Therapeutics|2013Cited by 46
Abstract C193: Biological evaluation of novel multi-targeted Aurora-B kinase inhibitor TAK-901 in xenograft modelsTakashi Satou, Ron de Jong, Takashi Hoshino et al.|Molecular Cancer Therapeutics|2009Cited by 0